Hannah Ratcliffe, M.Sc., of Waymark, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, she shared one of the best pieces of professional advice she had ever received, which is understanding that every context and situation in healthcare is different from the next.
FDA Updates for the Week of May 6: An Approval, a Delay and Two Ad Comm Meetings
May 11th 2024The FDA has approved a liquid mycophenolate to prevent organ rejections but delayed the approval of Moderna’s RSV vaccine. Regulators have set dates for advisory committee meetings for midomafetamine for PTSD and for donanemab in Alzheimer’s disease. Additionally, the agency has set review dates for a subcutaneous Opdivo and a pancreatic/lung cancer therapy.
Read More